Whalen Wealth Management Inc. Royalty Pharma PLC Transaction History
Whalen Wealth Management Inc.
- $159 Billion
- Q2 2025
A detailed history of Whalen Wealth Management Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Whalen Wealth Management Inc. holds 17,419 shares of RPRX stock, worth $654,606. This represents 0.39% of its overall portfolio holdings.
Number of Shares
17,419Holding current value
$654,606% of portfolio
0.39%Shares
1 transactions
Others Institutions Holding RPRX
# of Institutions
503Shares Held
289MCall Options Held
2.51MPut Options Held
940K-
Morgan Stanley New York, NY41MShares$1.54 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.7MShares$1.38 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$865 Million0.01% of portfolio
-
Baillie Gifford & CO18MShares$677 Million0.51% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$457 Million0.51% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $16.4B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...